These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8987126)

  • 1. Metabolic alterations of peripheral nerve in diabetes.
    Sima AA
    Semin Neurol; 1996 Jun; 16(2):129-37. PubMed ID: 8987126
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats.
    Shimoshige Y; Ikuma K; Yamamoto T; Takakura S; Kawamura I; Seki J; Mutoh S; Goto T
    Metabolism; 2000 Nov; 49(11):1395-9. PubMed ID: 11092500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study.
    Obrosova IG; Fathallah L; Lang HJ; Greene DA
    Diabetologia; 1999 Oct; 42(10):1187-94. PubMed ID: 10525658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polyol pathway in dysfunction of diabetic peripheral nerve.
    Greene DA; Lattimer SA
    Diabet Med; 1985 May; 2(3):206-10. PubMed ID: 3032500
    [No Abstract]   [Full Text] [Related]  

  • 5. [SG-210].
    Akira T; Naka H
    Nihon Rinsho; 1997 Nov; 55 Suppl():216-20. PubMed ID: 9434470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Correction of diabetic neuropathies using aldose reductase inhibitors and pikamilon].
    Kuchmerovskaia TM; Parkhomets PK; Donchenko GV; Obrosova IG; Klimenko AP; Kuchmerovskiĭ NA; Pakirbaeva LV; Efimov AS
    Vopr Med Khim; 1998; 44(6):559-64. PubMed ID: 10599142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of diabetic neuropathy with inhibitors of the aldose reductase enzyme.
    Green AJ; Jaspan JB
    J Diabet Complications; 1990; 4(4):138-44. PubMed ID: 2151223
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diabetic complication].
    Iwamoto Y
    Nihon Rinsho; 1991 Sep; 49(9):2136-40. PubMed ID: 1960879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of diabetic neuropathy].
    Frati-Munari AC; Ariza-Andraca CR
    Gac Med Mex; 1998; 134(1):85-92. PubMed ID: 9658700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.
    Ando H; Takamura T; Nagai Y; Kaneko S;
    J Diabetes Complications; 2006; 20(6):367-70. PubMed ID: 17070440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetic neuropathy: theories on its metabolic pathogenesis].
    Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3110-1. PubMed ID: 3328355
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA; Lattimer-Greene S; Sima AA
    Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic neuropathy].
    Yagihashi S
    Nihon Rinsho; 2006 Sep; Suppl 3():155-60. PubMed ID: 17022522
    [No Abstract]   [Full Text] [Related]  

  • 14. The sorbitol pathway and the complications of diabetes.
    Gabbay KH
    N Engl J Med; 1973 Apr; 288(16):831-6. PubMed ID: 4266466
    [No Abstract]   [Full Text] [Related]  

  • 15. Aetiogenesis of diabetic neuropathy.
    Ahuja MM
    J Assoc Physicians India; 1972 May; 20(5):378-82. PubMed ID: 4655513
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment for diabetic neuropathy.
    Watkins PJ
    Diabet Med; 1996 Dec; 13(12):1007-8. PubMed ID: 8973880
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenesis of diabetic neuropathies].
    Lalau JD; Arlot S; Quichaud J
    Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perspective for the treatment of diabetic neuropathy: translation from molecular studies to bedside].
    Yagihashi S; Yamagishi S; Wada R
    Rinsho Shinkeigaku; 2005 Nov; 45(11):966-8. PubMed ID: 16447775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and compressive neuropathy.
    Barrett SL; Dellon AL; Fleischli J; Gould JS; Wang C
    Foot Ankle Spec; 2010 Jun; 3(3):132-9. PubMed ID: 20508014
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural features of the aldose reductase and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Wilson DK; Petrash M; Quiocho FA
    Mol Vis; 1998 Sep; 4():19. PubMed ID: 9756955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.